Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; 1:100; loading ...; fig 3s2
| Gonzalo Gil E, Rapuano P, Ikediobi U, Leibowitz R, Mehta S, Coskun A, et al. Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members. elife. 2019;8: pubmed publisher
|
- flow cytometry; human; 1:100; loading ...; fig s5g
| Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
|
- flow cytometry; human; 1:200; fig s4
| Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
|
- flow cytometry; human; fig 3
| Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
|
- flow cytometry; human; fig 4
| Matsuda K, Hattori S, Kariya R, Komizu Y, Kudo E, Goto H, et al. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity. Biochem Biophys Res Commun. 2015;457:288-94 pubmed publisher
|
| Tian L, Xu B, Chen Y, Li Z, Wang J, Zhang J, et al. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity. Nat Cancer. 2022;3:1318-1335 pubmed publisher
|
| Cillo A, Somasundaram A, Shan F, Cardello C, Workman C, Kitsios G, et al. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden. Cell Rep Med. 2021;2:100476 pubmed publisher
|
| Ramien C, Yusko E, Engler J, Gamradt S, Patas K, Schweingruber N, et al. T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis. Cell Rep. 2019;29:810-815.e4 pubmed publisher
|
| Liu S, Dominska Ngowe M, DYKXHOORN D. Target silencing of components of the conserved oligomeric Golgi complex impairs HIV-1 replication. Virus Res. 2014;192:92-102 pubmed publisher
|
| Osman A, Bhuyan F, Hashimoto M, Nasser H, Maekawa T, Suzu S. M-CSF inhibits anti-HIV-1 activity of IL-32, but they enhance M2-like phenotypes of macrophages. J Immunol. 2014;192:5083-9 pubmed publisher
|
| Hu J, Zhang J, Cui J, Liang X, Lu R, Du G, et al. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine. 2013;62:141-5 pubmed publisher
|
| Al ofi E, Coffelt S, Anumba D. Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligands. PLoS ONE. 2012;7:e42217 pubmed publisher
|
| Sarra M, Caruso R, Cupi M, Monteleone I, Stolfi C, Campione E, et al. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-?-dependent epidermal hyperplasia. J Immunol. 2011;186:5435-42 pubmed publisher
|